Latest Updates
-
India’s Young Workforce May Face Heart Risks Even With A Normal BMI, Heart Health Report 2026 Finds -
Aishwarya Rai Bachchan Serves Dark Queen Glamour At L’Oréal Paris Le Défilé 2026 -
Pitru Paksha 2026: Does Ancestor Worship Bring Bad Luck If Rituals Aren’t Performed? Astrologer Explains -
World Heart Day 2026: Think You Are Fit? Your Heart May Tell a Different Story -
Dawn Phenomenon vs Somogyi Effect: What's The Difference? -
Tritiya Shraddha 2026: Who Should Perform It, Rituals To Follow And Why The Day Holds Significance -
World Heart Day 2026: The Heart Attack That Doesn't Look Like a Heart Attack -
Vighnaraja Sankashti Chaturthi 2026: Know The Date, Significance, Vrat Katha And Moonrise Fasting Rituals -
Taylor Swift Makes VMA History: All About Her Record-Breaking Night And Striking Red Carpet Look -
Bank Holidays October 2026: Check State-Wise List Before Visiting Your Branch
Scorpion Venom May Help Fight Brain Cancer

Researchers have found a brain-cancer therapy which uses a radioactive version of a protein found in scorpion venom. Traditional treatments like radiation and chemotherapy kill healthy cells in the process of controlling the cancer growth.
The sting of the scorpion Leiurus quinquestriatus unleashes a cocktail of neurotoxins containing a peptide that is non-toxic to humans but binds to tumour cells. In tests, the peptide has invaded tumours in breast, skin, brain and lung tissue while leaving healthy cells untouched.
"It's as if the tumours collect it," New Scientist quoted Michael Egan of the company TransMolecular in Cambridge, Massachusetts, as saying.
To determine if the peptide could deliver lethal doses of radioactivity to cancer cells, researchers have now attached radioactive iodine isotopes to it.
In an experiment, the researchers injected this agent directly into the tumours of 59 people suffering from inoperable brain cancer. All the patients have now died, but those receiving a higher dose lived for three months longer, on average.
Researchers at the University of Chicago in Illinois have begun injecting TM601 into the bloodstream of people with different types of malignant brain cancer. This latest trial will allow the company to test whether it can seek out and kill secondary tumours throughout the body, as well as known primary ones.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
